Evidence map›Paper›PMID 42519248›Full record

ArticleCureus2026

Paget's Disease Unveiled in a Primary Care Setting: A Case of High Alkaline Phosphatase.

Nikhil A Nandkumar, Aruna Chakrala

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nikhil A NandkumarNeuroscience, University College London, London, GBR.
Aruna ChakralaInternal Medicine, Plainsboro Princeton Medical Associates PC, Plainsboro, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paget's disease of bone (PDB) is a moderately common clinical entity that causes bone deformities and focal areas of disorganized new bone formation. It is characterized by abnormal bone remodeling, leading to enlarged and weakened bones. Although often asymptomatic, it can present with localized pain, deformity, or fractures. Elevated alkaline phosphatase (ALP) levels, which are bone-specific, are common biochemical findings of PDB and can be treated with bisphosphonates; however, diagnosing it based on clinical presentation may be challenging due to the asymptomatic nature of the disease, as well as the various factors, causes, and tests required for an accurate diagnosis. We present the case of a 67-year-old male patient who initially presented to the clinic with a right heel fracture and right hip pain, which turned out to be PDB marked by an increased ALP level. A radionuclide bone scan confirmed right pelvic bone deformity and prompted the prescription of zoledronic acid. Lab work was repeated six months later, and a repeat radionuclide bone scan will be performed if the patient experiences any new symptoms. With such cases often being overlooked, especially in primary care settings, this report emphasizes the vital need to monitor biochemical markers, such as ALP. This report highlights the diagnostic process and clinical considerations involved in identifying and managing PDB.

Indexed as

alkaline phosphataseosteoclastspaget’s diseaseparamyxovirussqstm1zolendric acid

Identifiers

PMID42519248
PMCPMC13381142

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.